Evidence map›Paper›PMID 31750312›Full record

ReviewFrontiers in molecular biosciences2019

Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Kuldeep Dhama, Shyma K Latheef, Maryam Dadar, Hari Abdul Samad, Ashok Munjal, Rekha Khandia, Kumaragurubaran Karthik, Ruchi Tiwari, Mohd Iqbal Yatoo, Prakash Bhatt and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 2 syntheses or guidelines pooled it, 312 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. NewLife (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Cortisol-CXFrontiers in immunology · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Kuldeep DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Shyma K LatheefDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Maryam DadarRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj, Iran.
Hari Abdul SamadDivision of Physiology and Climatology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Ashok MunjalDepartment of Genetics, Barkatullah University, Bhopal, India.
Rekha KhandiaDepartment of Genetics, Barkatullah University, Bhopal, India.
Kumaragurubaran KarthikCentral University Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Chennai, India.
Ruchi TiwariDepartment of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan, Mathura, India.
Mohd Iqbal YatooDivision of Veterinary Clinical Complex, Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir, Srinagar, India.
Prakash BhattTeaching Veterinary Clinical Complex, College of Veterinary and Animal Sciences, Govind Ballabh Pant University of Agriculture and Technology, Pantnagar, India.
Sandip ChakrabortyDepartment of Veterinary Microbiology, College of Veterinary Sciences and Animal Husbandry, Agartala, India.
Karam Pal SinghDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Hafiz M N IqbalTecnologico de Monterrey, School of Engineering and Sciences, Monterrey, Mexico.
Wanpen ChaicumpaDepartment of Parasitology, Faculty of Medicine, Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Sunil Kumar JoshiDivision of Hematology, Oncology and Bone Marrow Transplantation, Department of Microbiology & Immunology, Department of Pediatrics, University of Miami School of Medicine, Miami, FL, United States.
Indian Veterinary Research Institute · INBarkatullah University · INGovind Ballabh Pant University of Agriculture and Technology · INRazi Vaccine and Serum Research Institute · IRSher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir · INSiriraj Hospital · THTamil Nadu Veterinary and Animal Sciences University · INTecnológico de Monterrey · MXUniversity of Miami · USUttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go-Anusandhan Sansthan · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various internal and external factors negatively affect the homeostatic equilibrium of organisms at the molecular to the whole-body level, inducing the so-called state of stress. Stress affects an organism's welfare status and induces energy-consuming mechanisms to combat the subsequent ill effects; thus, the individual may be immunocompromised, making them vulnerable to pathogens. The information presented here has been extensively reviewed, compiled, and analyzed from authenticated published resources available on Medline, PubMed, PubMed Central, Science Direct, and other scientific databases. Stress levels can be monitored by the quantitative and qualitative measurement of biomarkers. Potential markers of stress include thermal stress markers, such as heat shock proteins (HSPs), innate immune markers, such as Acute Phase Proteins (APPs), oxidative stress markers, and chemical secretions in the saliva and urine. In addition, stress biomarkers also play critical roles in the prognosis of stress-related diseases and disorders, and therapy guidance. Moreover, different components have been identified as potent mediators of cardiovascular, central nervous system, hepatic, and nephrological disorders, which can also be employed to evaluate these conditions precisely, but with stringent validation and specificity. Considerable scientific advances have been made in the detection, quantitation, and application of these biomarkers. The present review describes the current progress of identifying biomarkers, their prognostic, and therapeutic values.

Indexed as

acute phase proteinsbiomarkersdiagnosisheat shock proteinsmiRNAsprognosisstresstherapeutic values

Identifiers

PMID31750312
PMCPMC6843074
OpenAlexW2980977859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.